Cipher Pharmaceuticals Inc.
TSX:CPH.TODrug Manufacturers - Specialty & Generic
Healthcare
$13.05 +0.94%
+$0.15 today
- Market cap
- $331.67M
- Beta
- 0.48
- P/E (TTM)
- 9.3
- EPS (TTM)
- $1.22
52W Low $11.98High $20.56
Volume 0.04M
Average 0.03M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$30.25M
FY 2025 · Annual
+54.7% YoYInvesting Cash Flow
-$72,242.00
FY 2025 · Annual
Financing Cash Flow
-$41.18M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 7.76M | 26.64M | 20.38M | 11.55M | 27.33M |
| Depreciation & Amortization | 701K | 989K | 1.23M | 4.02M | 7.23M |
| Deferred Income Tax | (114K) | (14.31M) | (2.74M) | (8.64M) | (10.36M) |
| Stock-Based Compensation | 139K | 403K | 1.19M | 1.07M | 1.74M |
| Change in Working Capital | 4.68M | (3.03M) | (3.28M) | 8.95M | 5.32M |
| Accounts Receivables | 2.56M | (144K) | 1.71M | (8.77M) | 2.7M |
| Inventory | (758K) | (502K) | (830K) | 3.6M | (2.44M) |
| Accounts Payables | (1.23M) | (1.45M) | 532K | 1.28M | 527.07K |
| Other Working Capital | 4.11M | (940K) | (4.69M) | 12.85M | 4.53M |
| Other Non-Cash Items | 652K | (109K) | (788K) | 2.6M | (1.01M) |
| Operating Cash Flow | 13.81M | 10.58M | 16M | 19.55M | 30.25M |
| Capital Expenditures | 0 | (81K) | (144K) | (44K) | (28.49K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 132.28K |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | (123K) | (80M) | 0 |
| Investing Cash Flow | 0 | (81K) | (144K) | (80.04M) | (72.24K) |
| Debt Repayment | (828K) | (56K) | (111K) | 39.79M | (35.61M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 218.76K |
| Common Stock Repurchased | (1.72M) | (1.99M) | (5.56M) | (176K) | (5.48M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 75K | 132K | 426K | (317K) | (311.36K) |
| Financing Cash Flow | (2.47M) | (1.91M) | (5.24M) | 39.3M | (41.18M) |
| Effect of Forex Changes | 62K | (292K) | 378K | (786K) | (194.92K) |
| Net Change in Cash | 11.41M | 8.29M | 10.99M | (21.99M) | (11.2M) |
| Free Cash Flow | 13.81M | 10.49M | 15.98M | 19.5M | 30.22M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$27.3M
+ D&A$7.2M
+ Stock-Based Comp$1.7M
- Deferred Tax-$10.4M
+ Working Capital$5.3M
- Other Non-Cash-$1.0M
= Operating Cash Flow$30.2M
- Capex-$28.5K
= Free Cash Flow$30.2M
Analysis
FY2025 free cash flow is $30.2M. FCF conversion is 110.6% of net income. Operating cash flow was $30.2M, with capex of -$28.5K. The largest bridge item is Deferred Tax at -$10.4M.
Recent Filings
Recent regulatory filings
No filings found.
Does CPH.TO generate free cash flow?
Cipher Pharmaceuticals Inc. (CPH.TO) generated $30.22M of free cash flow in fiscal 2025.
How much operating cash flow does CPH.TO produce?
Operating cash flow was $30.25M, before capital expenditures of $28,486.00.
Continue the stock analysis
Jump to another research area for this company.